Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
3HP TPT completion rate of 92%, with few adverse events leading to 3HP discontinuation, providing evidence of the scalability and safety of 3HP TPT among PLHIV in Indian health program settings.
Authors
- Hitesh Solanki (ORCID: https://orcid.org/0000-0001-8687-0039)
- Amita Gupta (ORCID: https://orcid.org/0000-0001-7036-2718)
- Praveen Malik (ORCID: https://orcid.org/0000-0001-7075-8106)
- Nishi Suryavanshi (ORCID: https://orcid.org/0000-0001-8917-0302)
- Vidya Mave (ORCID: https://orcid.org/0000-0001-8509-4517)
- Richard E. Chaisson (ORCID: https://orcid.org/0000-0003-4710-925X)
- Bharat Randive
- R. Borse
- S. K. Mattoo
Institutions
- Government Medical College (IN)
- Johns Hopkins University (US)
- Government of India (IN)
- Johns Hopkins Medicine (US)
- Centre for Materials for Electronics Technology (IN)
- Ministry of Health and Family Welfare (IN)
- World Health Organization - India (IN)
- Government Medical College (IN)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2024-09-01
- DOI
- https://doi.org/10.5588/ijtldopen.23.0609
- Citations
- 5
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 1.95